Jörge Beleta

2.0k total citations
50 papers, 1.3k citations indexed

About

Jörge Beleta is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Jörge Beleta has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 16 papers in Physiology and 9 papers in Immunology. Recurrent topics in Jörge Beleta's work include Phosphodiesterase function and regulation (15 papers), Asthma and respiratory diseases (13 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (10 papers). Jörge Beleta is often cited by papers focused on Phosphodiesterase function and regulation (15 papers), Asthma and respiratory diseases (13 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (10 papers). Jörge Beleta collaborates with scholars based in Spain and Italy. Jörge Beleta's co-authors include Teresa Domènech, José Palacios, Amadeu Gavaldà, Esteban Morcillo, Julio Cortijo, Hamish Ryder, Vı́ctor Segarra, Montserrat Miralpeix, Josep Bou and Jesús Llenas and has published in prestigious journals such as The Journal of Immunology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Jörge Beleta

49 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jörge Beleta Spain	22	579	393	274	260	189	50	1.3k
Teresa Domènech Spain	17	434 0.7×	197 0.5×	282 1.0×	108 0.4×	125 0.7×	29	915
David Raeburn United States	27	841 1.5×	1.1k 2.7×	124 0.5×	536 2.1×	157 0.8×	68	1.8k
Dale B. Evans United States	19	599 1.0×	269 0.7×	280 1.0×	86 0.3×	116 0.6×	31	1.2k
Michael G. Hahn Germany	12	457 0.8×	293 0.7×	128 0.5×	92 0.4×	32 0.2×	26	1.1k
Torsten Minuth Germany	14	584 1.0×	563 1.4×	90 0.3×	130 0.5×	34 0.2×	17	1.2k
R. Ouedraogo Belgium	16	456 0.8×	391 1.0×	162 0.6×	85 0.3×	123 0.7×	27	1.6k
Ivan Milicic United States	19	554 1.0×	202 0.5×	127 0.5×	44 0.2×	62 0.3×	42	1.1k
Klaus Pönicke Germany	22	527 0.9×	323 0.8×	98 0.4×	110 0.4×	106 0.6×	62	1.3k
James S. Polakowski United States	17	405 0.7×	134 0.3×	111 0.4×	37 0.1×	65 0.3×	39	900
Jo Mori Japan	17	346 0.6×	170 0.4×	173 0.6×	44 0.2×	95 0.5×	66	945

Countries citing papers authored by Jörge Beleta

Since Specialization

Citations

This map shows the geographic impact of Jörge Beleta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörge Beleta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörge Beleta more than expected).

Fields of papers citing papers by Jörge Beleta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörge Beleta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörge Beleta. The network helps show where Jörge Beleta may publish in the future.

Co-authorship network of co-authors of Jörge Beleta

This figure shows the co-authorship network connecting the top 25 collaborators of Jörge Beleta. A scholar is included among the top collaborators of Jörge Beleta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörge Beleta. Jörge Beleta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gavaldà, Amadeu, Israel Ramos, Elena Calama, et al.. (2014). The in vitro and in vivo profile of aclidinium bromide in comparison with glycopyrronium bromide. Pulmonary Pharmacology & Therapeutics. 28(2). 114–121. 40 indexed citations

Aparici, Mònica, Mireia Gómez-Angelats, Dolors Vilella, et al.. (2012). Pharmacological Characterization of Abediterol, a Novel Inhaled β2-Adrenoceptor Agonist with Long Duration of Action and a Favorable Safety Profile in Preclinical Models. Journal of Pharmacology and Experimental Therapeutics. 342(2). 497–509. 44 indexed citations

Gavaldà, Amadeu, et al.. (2011). Aclidinium bromide, a novel long-acting muscarinic antagonist for COPD with improved preclinical renal and urinary safety profile. Life Sciences. 90(7-8). 301–305. 7 indexed citations

Gavaldà, Amadeu, Elena Calama, J.L. Montero, et al.. (2011). Synthesis and biological activity of pyrido[3′,2′:4,5]furo[3,2-d]pyrimidine derivatives as novel and potent phosphodiesterase type 4 inhibitors. European Journal of Medicinal Chemistry. 46(10). 4946–4956. 14 indexed citations

Gavaldà, Amadeu, Montserrat Miralpeix, Israel Ramos, et al.. (2009). Characterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile. Journal of Pharmacology and Experimental Therapeutics. 331(2). 740–751. 108 indexed citations

Domínguez, Eduardo, Marián Castro, José Brea, et al.. (2008). A new chemical tool (C0036E08) supports the role of adenosine A2B receptors in mediating human mast cell activation. Biochemical Pharmacology. 76(7). 912–921. 7 indexed citations

Nueda, Arsenio, José Luis Dı́az, Jörge Beleta, et al.. (2006). New pyrrolopyrimidin-6-yl benzenesulfonamides: Potent A2B adenosine receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(14). 3642–3645. 20 indexed citations

Nueda, Arsenio, Teresa Domènech, Núria Godessart, et al.. (2006). Phosphodiesterase 7A1 is expressed in human CD4+ naïve T cells at higher levels than in CD4+ memory cells and is not required during their CD3/CD28-dependent activation. Cellular Immunology. 242(1). 31–38. 6 indexed citations

Fonquerna, Sı́lvia, M. Miralpeix, Lluı́s Pagès, et al.. (2005). Synthesis and structure–activity relationships of piperidinylpyrrolopyridine derivatives as potent and selective H1 antagonists. Bioorganic & Medicinal Chemistry Letters. 15(4). 1165–1167. 12 indexed citations

10.

Piaz, Vittorio Dal, Claudia Vergelli, Maria Paola Giovannoni, et al.. (2002). Synthesis and Evaluation of Some Pyrazolo[3,4-d]pyridazinones and Analogues as PDE 5 Inhibitors Potentially Useful as Peripheral Vasodilator Agents. Journal of Enzyme Inhibition and Medicinal Chemistry. 17(4). 227–233. 22 indexed citations

11.

Cortijo, Julio, Victoria Villagrasa, Ramón Pons, et al.. (1999). Bronchodilator and anti‐inflammatory activities of glaucine: In vitro studies in human airway smooth muscle and polymorphonuclear leukocytes. British Journal of Pharmacology. 127(7). 1641–1651. 57 indexed citations

12.

Beleta, Jörge, et al.. (1999). Anticholinergic effects of desloratadine, the major metabolite of loratadine, in rabbit and guinea-pig iris smooth muscle. European Journal of Pharmacology. 374(2). 249–254. 27 indexed citations

13.

Santamaria‐Babí, Luis F., Rosa Torres, Hamish Ryder, Jörge Beleta, & José Palacios. (1999). Prostaglandin E2 Inhibits SEB–Mediated Induction of the Cutaneous Lymphocyte–Associated Antigen. International Archives of Allergy and Immunology. 118(2-4). 351–352. 4 indexed citations

14.

Xaus, Jordi, et al.. (1999). Adenosine Inhibits Macrophage Colony-Stimulating Factor-Dependent Proliferation of Macrophages Through the Induction of p27 kip-1 Expression. The Journal of Immunology. 163(8). 4140–4149. 71 indexed citations

15.

Domènech, Teresa, Jörge Beleta, & José Palacios. (1997). Characterization of human serotonin 1D and 1B receptors using [ 3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist. Naunyn-Schmiedeberg s Archives of Pharmacology. 356(3). 328–334. 59 indexed citations

16.

Piaz, Vittorio Dal, Maria Paola Giovannoni, José María Fernández Palacios, et al.. (1997). Novel Heterocyclic-Fused Pyridazinones as Potent and Selective Phosphodiesterase IV Inhibitors. Journal of Medicinal Chemistry. 40(10). 1417–1421. 62 indexed citations

17.

Munujos, Petraki, J Coll, Jörge Beleta, Francesc González‐Sastre, & F.-Javier Gella. (1996). Brain pyruvate oxidation in experimental thiamin-deficiency encephalopathy. Clinica Chimica Acta. 255(1). 13–25. 21 indexed citations

18.

Cortijo, Julio, Josep Bou, Jörge Beleta, et al.. (1993). Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus. British Journal of Pharmacology. 108(2). 562–568. 95 indexed citations

19.

Canalías, Francesca, et al.. (1992). Purification and characterization of streptolysin o from Streptococcus pyogenes. International Journal of Biochemistry. 24(7). 1073–1079. 5 indexed citations

20.

Fernández, Andrés G., Jaume Puig, Jörge Beleta, et al.. (1992). Pancopride, a potent and long-acting 5-HT3 receptor antagonist, is orally effective against anticancer drug-evoked emesis. European Journal of Pharmacology. 222(2-3). 257–264. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact